/Companies

Pathalys

Research Triangle Park, US · Founded 2021 · 18 employees on LinkedIn · 7 known investors

Find your way into Pathalys

Sign up to see every warm intro you have to Pathalys

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Pathalys team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Pathalys Pharma is a biotechnology company developing and improving therapeutic treatments for patients with chronic kidney disease.

Founders & leadership

Pathalys was founded in 2021 by BT Slingsby.

BSBT Slingsby
BT SlingsbyCo-Founder & Executive Chairman

Investors · 7

Also in the syndicate · 2

J.P. Morgan Life Sciences Private CapitalTCGXlead

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Founder mafia

2 people who came through Pathalys went on to found or lead other companies.

In the news

Frequently asked questions

What does Pathalys do?
Pathalys Pharma is a biotechnology company developing and improving therapeutic treatments for patients with chronic kidney disease.
Who founded Pathalys?
Pathalys was founded by BT Slingsby in 2021.
Who are Pathalys's investors?
Pathalys's investors include Abingworth, Catalys Pacific, OrbiMed, Samsara BioCapital, KB Investment.
Where is Pathalys headquartered?
Pathalys is headquartered in Research Triangle Park, US.